Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022

SELL
$0.41 - $1.24 $42,669 - $129,048
-104,071 Closed
0 $0
Q1 2022

May 13, 2022

SELL
$0.62 - $1.17 $4,542 - $8,571
-7,326 Reduced 6.58%
104,071 $68,000
Q4 2021

Feb 11, 2022

SELL
$1.09 - $1.89 $3,631 - $6,297
-3,332 Reduced 2.9%
111,397 $121,000
Q3 2021

Nov 12, 2021

SELL
$1.44 - $2.73 $3,925 - $7,441
-2,726 Reduced 2.32%
114,729 $209,000
Q2 2021

Aug 13, 2021

SELL
$2.63 - $3.67 $17,865 - $24,930
-6,793 Reduced 5.47%
117,455 $310,000
Q1 2021

May 07, 2021

BUY
$2.82 - $5.6 $924 - $1,836
328 Added 0.26%
124,248 $447,000
Q4 2020

Feb 12, 2021

SELL
$2.09 - $3.09 $7,434 - $10,991
-3,557 Reduced 2.79%
123,920 $312,000
Q3 2020

Nov 04, 2020

SELL
$2.39 - $3.43 $6,926 - $9,940
-2,898 Reduced 2.22%
127,477 $321,000
Q2 2020

Aug 12, 2020

BUY
$2.2 - $3.71 $45,641 - $76,967
20,746 Added 18.92%
130,375 $428,000
Q1 2020

May 04, 2020

BUY
$1.9 - $4.98 $17,322 - $45,402
9,117 Added 9.07%
109,629 $269,000
Q4 2019

Feb 05, 2020

SELL
$3.95 - $5.35 $3,345 - $4,531
-847 Reduced 0.84%
100,512 $474,000
Q3 2019

Nov 08, 2019

SELL
$4.13 - $6.94 $2,911 - $4,892
-705 Reduced 0.69%
101,359 $434,000
Q2 2019

Aug 13, 2019

BUY
$3.98 - $6.2 $72,284 - $112,604
18,162 Added 21.65%
102,064 $595,000
Q1 2019

May 06, 2019

SELL
$2.0 - $4.4 $5,442 - $11,972
-2,721 Reduced 3.14%
83,902 $323,000
Q4 2018

Feb 13, 2019

SELL
$1.61 - $3.62 $1,072 - $2,410
-666 Reduced 0.76%
86,623 $162,000
Q3 2018

Nov 09, 2018

BUY
$2.26 - $3.27 $3,557 - $5,146
1,574 Added 1.84%
87,289 $279,000
Q2 2018

Aug 08, 2018

BUY
$3.02 - $4.94 $5,212 - $8,526
1,726 Added 2.06%
85,715 $259,000
Q1 2018

May 07, 2018

SELL
$3.46 - $5.14 $15,628 - $23,217
-4,517 Reduced 5.1%
83,989 $329,000
Q4 2017

Feb 09, 2018

BUY
$4.0 - $6.54 $1,672 - $2,733
418 Added 0.47%
88,506 $366,000
Q3 2017

Nov 09, 2017

BUY
$4.99 - $6.57 $439,559 - $578,738
88,088
88,088 $541,000

Others Institutions Holding TCRT

About Alaunos Therapeutics, Inc.


  • Ticker TCRT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 216,182,000
  • Market Cap $424M
  • Description
  • Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive TCR engineered T-cell therapies. It develops TCR Library, which is in Phase I/II clinical trial for ten TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancrea...
More about TCRT
Track This Portfolio

Track American International Group, Inc. Portfolio

Follow American International Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.